Product Description
The global interbody fusion market was valued at over $3.1 billion in 2024. This is expected to increase over the forecast period at a CAGR of 4.3% to reach over $4.2 billion.
The full report suite on the global market for interbody fusion includes the subsegments anterior lumbar interbody fusion (ALIF), posterior lumbar interbody fusion (PLIF), transforaminal lumbar interbody fusion (TLIF), cervical interbody fusion (CIF), VBR/corpectomy and expendable interbody devices.
This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL INTERBODY FUSION DEVICE MARKET TRENDS
The biggest limiting factor for the spinal fusion markets is the development of MIS interbody devices. Patients are drawn to the advantages of using less invasive techniques. Minimally invasive techniques reduce muscle and tissue damage at the surgical site and decrease complication frequencies as well as intraoperative times. Clinical outcomes have been largely positive, further favoring the use of minimally invasive techniques over open procedures. This has been a major limiter for more developed markets, and it is expected that in the near future, it will be one for less mature markets.
GLOBAL INTERBODY FUSION DEVICE MARKET SHARE INSIGHTS
- Medtronic was the leading competitor in 2024. Some parts of the company’s success are because of its Elevate™ expandable cage, Anatomic® PTC and Cornerstone® PSR cages in the cervical segment, in addition to its Capstone® cage. The company had Cornerstone L ASR® machined bone system and other dowels and wedges. Medtronic also manufactures its ARTiC™ line of 3D-printed metal devices. The company was also active in VBR and first in the expandable market. Medtronic held the leading position in the interbody device market in North America and some parts of Asia-Pacific.
- DePuy Synthes was the second-leading competitor in the interbody device market. The company offers its radiolucent lumbar interbody fusion cages made of carbon fiber reinforced polymer (CFRP) in addition to several other bone and non-bone devices. Most of the shares held by DePuy Synthes is due to its leading shares in Western Europe and Asia-Pacific.
- Globus Medical/NuVasive was another leading competitor in the global cervical fixation market in 2024. The company underwent a merger in 2023 and is expected to make gains in market share over the forecast period due to their complementary global scale, expanded commercial reach, comprehensive portfolios in spine and orthopedics, commitment to product development and surgeon education and increased operational capabilities.
MARKET SEGMENTATION SUMMARY
- Anterior Lumbar Interbody Fusion (ALIF) Market
- Posterior Lumbar Interbody Fusion (PLIF) Market
- Transforaminal Lumbar Interbody Fusion (TLIF) Market
- Cervical Interbody Fusion (CIF) Device Market
- VBR/Corpectomy Device Market
- Expendable Interbody Device Market
GLOBAL RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
